v3.26.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets    
Cash $ 1,974,500
Prepaid expenses and other current assets 126,558
Total Current Assets 2,101,058
Non-current assets    
Deferred offering costs 106,812
Investments held in Trust Account 115,627,232
Total Non-Current Assets 115,627,232 106,812
TOTAL ASSETS 117,728,290 106,812
Current liabilities    
Other payable 446 397
Total Current Liabilities 190,997 140,123
Total Liabilities 190,997 140,123
Commitments and Contingencies (Note 6)
Shareholders’ Equity (Deficit)    
Preference shares, no par value; 1,000,000 shares authorized; none issued and outstanding as of March 31, 2026 and December 31, 2025
Additional paid-in capital 1,420,411 25,000
Retained earnings (Accumulated deficit) 489,650 (58,311)
Total Shareholders’ Equity (Deficit) 1,910,061 (33,311)
TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ EQUITY (DEFICIT) 117,728,290 106,812
Related Party    
Current liabilities    
Accrued administrative services fee – related party 20,000
Promissory note – related party 170,551 139,726
Class A ordinary shares    
Current liabilities    
Class A ordinary shares, no par value; 100,000,000 shares authorized; 11,500,000 shares issued and outstanding subject to possible redemption as of March 31, 2026 115,627,232
Shareholders’ Equity (Deficit)    
Ordinay shares, value
Class B ordinary shares    
Shareholders’ Equity (Deficit)    
Ordinay shares, value [1]
[1] As a result of the underwriters’ representative’s full exercise of its over-allotment option to purchase 1,500,000 units on February 3, 2026, no shares were subject to forfeiture.